FTC clears Teva buy of Allergan unit; Kadmon sinks
2:40 PM ET Wed, 27 July 2016
The FTC has approved Teva's acquisition of an Allergan unit. And drug developer Kadmon sinks on its first day as a publicly-traded company. And a breakthrough in ALS research? CNBC's Meg Tirrell reports.